|
|
◄ Mycoplasma
►
Mycoplasma Registry
for gulf war illness & chronic
fatigue syndrome
November 2, 1999
Original Video Script for CDC's Nov 2nd Chronic
Fatigue Syndrome Coordinating Committee Meeting
Mycoplasmas Are Contagious
by Sean & Leslee Dudley
Thousands of people diagnosed with Chronic Fatigue Syndrome, Fibromyalgia
and Gulf War Illness, from all over our country and the world have tested
positive for mycoplasmas. Mycoplasmas are contagious. Fifty-six percent
of the victims on our MYCOPLASMA REGISTRY had an airborne, contagious onset.
Mycoplasmas: Family Disease It is a slow growing epidemic that is infecting
and devastating entire families. Almost 60% of the Chronic Fatigue Syndrome
patients on our registry, have more than one person in their households
who have tested positive for mycoplasma infections. These are husbands and
wives, fathers and sons, mothers and daughters, mothers & sons, extended
family members and even household pets. [Slides of families tested positive
Dr. Nicolson's PCR Blood Test
Now, there is an accurate PCR blood test and protocol designed by Drs.
Garth and Nancy Nicolson, to diagnose and treat these mycoplasma infections.
These tests are far more accurate than previous antibody or blood culture
tests. Once long term antibiotic treatment is started, patients begin recovering.
No new drugs need to be developed. We and hundreds of MYCOPLASMA REGISTRY
members are recovering after one to three years on antibiotics. Unfortunately
the CDC's criminal diversion of CFS research funds has caused delays in
diagnosis and treatment. Some patients who have suffered years of infections
may need to take antibiotics for the rest of their lives. [Slide of Dr.
Nicolson at The Institute for Molecular Medicine]
Dr. Lo's Mycoplasma Patent
The overwhelming body of evidence from researchers forces us to conclude
that there is a national, if not global epidemic. Even Dr. Shyh-Ching Lo,
pathologist for the Department of Defense who discovered and patented
mycoplasma fermentans incognitus and mycoplasma penetrans states in his
own patents, that Mycoplasma fermentans is the cause of Chronic Fatigue
Syndrome.
United States Patent Patent Number: 5,242,820
Date of Patent: Sep. 7, 1993
Pathogenic Mycoplasma Inventor:
Shyh-Ching Lo, Potomac, Md. Assignee: American Registry of Pathology Washington,
D.C [Dept. of Defense]
Filed: June 6, 1991 [originally applied for June 18, 1986]
"O. Other Disease States in Which M. fermentans incognitus Has Been Implicated
In addition to AIDS, M. fermentans incognitus has been implicated in a number
of other Disease states including Chronic Fatigue Syndrome, Wegener's Disease,
Sarcoidosis, respiratory distress syndrome, Kiku-chi's disease, autoimmune
diseases such as Collagen Vascular Disease and Lupus, and chronic debilitating
diseases such as Alzheimer's Disease. M. fermentans incognitus may be either
a causative agent of these diseases or a key co-factor in these diseases.
P. Treatment of M. fermentans incognitus Infection M. fermentans incognitus
is known to be sensitive to a number of antibiotics, including doxycycline,
quinalones such as ciprofloxacin, chloramphenicol and tetracycline. Therefore,
effective treatment of any of the above implicated diseases should include
administration of antibiotics to which M. fermentans incognitus is sensitive."
[Slides: Dr. Lo's portrait, patent cover, patent excerpt]
Congressman Bob Filner
We have enlisted Congressman Bob Filner and others for their support in
bringing this epidemic to the attention of Congress. [Slide of Congressman
Bob Filner of San Diego, CA, Senior Democrat on the Veterans' Affairs
Committee, expert on Gulf War Illness] Must Reclassify Mycoplasmas The
CDC, FDA and NIH, all have sections devoted to mycoplasma research. They
acknowledge that mycoplasmas are contagious to farm animals such as pigs,
chickens and cattle, causing arthritis, stunted growth, even death. Vaccines
have been developed and used on animals for years. Yet, all these health
organizations continue to deny that mycoplasmas can spread through the
human population or cause illness. We demand that the CDC reclassify mycoplasmas
as a reportable contagious disease if found in the blood and that they
require every diagnosis of Chronic Fatigue Syndrome to be reported by
physicians.
Recall CDC's CFS Booklet
The CDC must immediately recall its May 1999 Chronic Fatigue Syndrome
booklet. The booklet advises patients not to be tested for mycoplasma infection.
A new booklet should recommend testing for mycoplasma and other infections,
and advise doctors that Chronic Fatigue Syndrome patients are responding
to antibiotic treatment. The CDC must stop implying that this is a psychological
disorder and stop recommending medications that lead to severe addiction.
d. "Theoretical and Experimental
Tests A number of tests, some of which are offered commercially, have no
demonstrated value for the diagnosis of CFS. These tests should not be
performed unless required for diagnosis of a suspected exclusionary condition
(e.g., MRI to rule out suspected multiple sclerosis) or unless they are
part of a scientific study. In the latter case, written informed consent
of the patient is required. No diagnostic tests for infectious agents,
such as Epstein-Barr virus. enteroviruses, retroviruses. Human herpesvirus
6. Candida albicans. and Mycoplasma incognita, are diagnostic for CFS and
as such should not be used (except to identify an illness that would exclude
a CFS diagnosis, such as mononucleosis). In addition, no immunologic tests,
including cell profiling tests such as measurements of natural killer cell
(NK) number or function, cytokine tests (e.g., interleukin-1, interleukin-6,
or interferon), or cell marker tests (e.g., CD25 or CD16), have ever been
shown to have value for diagnosing CFS. Other tests that must be regarded
as experimental for making the diagnosis of CFS include the tilt table
test for NMH, and imaging techniques such as MRI, PET-scan, or SPECT-scan.
Reports of a pathway marker for CFS as well as a urine marker for CFS are
undergoing further study; however, neither is considered useful for diagnosis
at this time. " [page 10]
Double Blind Studies Needed The CDC & NIH must fund double-blind studies
with antibiotics to determine which are most effective against specific
strains of mycoplasmas or we will demand that Congress take away funding
from the CDC and NIH as it has taken away funding from the DOD for Gulf
War Illness.
Mycoplasma Registry 303 N 47th Street, J-10 San Diego, CA 92102-5961 telephone:
619-266-1116 e-mail: mycoreg@juno.com © 1999 Sean & Leslee Dudley
Mycoplasma Registry
for gulf war illness & chronic fatigue
syndrome
April 22, 1999
Letter to the Chronic Fatigue Syndrome
Coordinating Committee
by Sean & Leslee Dudley
Thousands of civilians and military personnel throughout the world are now
testing positive for Mycoplasmas fermentans incognitus; 80% with Chronic
Fatigue Syndrome and 65% with Gulf War Illness. It is long overdue for CFS
be acknowledged as a contagious disease, and not a psychological ailment.
Dr. Garth Nicolson has provided accurate diagnostic PCR blood tests for
the detection of Mycoplasmas. The VA is starting a double blind study for
Mycoplasma using Dr. Nicolson's PCR blood test and antibiotic protocol.
People on our Registry test positive for one to four species of Mycoplasmas.
They are taking antibiotics, recovering and testing negative in one to three
years. It's been a decade since we were both diagnosed with CFS. We caught
it before the Gulf War began; Sean with irritable bowel syndrome and Leslee
with Fibromyalgia and Lupus. We tried. many CFS treatments including IV
gamma globulin, a double blind interferon trial and various medications.
(Leslee is on page 96 of Dr. Jay Goldstein's "Betrayal of the Brain").
As Gulf War Illness became known, we recognized the symptoms as CFS/like.
We tested positive for Mycoplasma fermentans incognitus, started antibiotic
treatment and began recovering. Sean was the first civilian to be retested
using a bone marrow biopsy. After seven months on antibiotics; he still
tested positive. Two years ago, we appeared on national TV as civilians
who had GWI/CFS with the good news that there was a PCR blood test and an
antibiotic protocol. Responding to hundreds of phone calls, we started asking
questions and keeping statistics. These are some of our preliminary findings.
The Registry is 84% civilians, 16% military, 59% women, 28% men and 13%
children.
How Did Their Illness Start?
56% attributed it to a probable airborne
exposure. The 20% who caught it in a hospital setting after an accident
or surgery, also indicates its contagious nature. The people with trauma
or chemical exposure may have been previously infected, but the disease
only fully developed after their immune systems were suppressed. However,
6 % caught it from vaccinations that may have been contaminated with mycoplasma
or experimental live mycoplasma vaccines.
How Long Before They Were Disabled?
When Did Their Symptoms First Begin?
In the 1970's and 1980's, people became infected with M. fermentans after
experimental injections while in the Armed Forces or in civilian prisons,
as in Huntsville, TX. Their families subsequently became infected. As it
slowly spread into the population, the numbers spiked as our troops were
given vaccines in preparation for the Gulf War. The incubation period is
2 to 18 months.
Occupation At Onset?
People are likely to catch this disease as a result of their occupations.
Contagiousness is demonstrated by the largest group being health care
workers and the next largest group being teachers and students. It passes
into the civilian community by people who have frequent contact with the
public such as sales people, receptionists, lawyers, entertainers, waitresses
and clerks. People we counted as having military connections, worked at
or near military bases, in aerospace fields, dockworkers, merchant marines,
truckers and airline personal.
Are Other Family Members Or Friends Infected?
With couples, when the first person to become infected is a man, 84% of
the female partners tested positive. If the first partner to become infected
is a female, 48% of the male partners tested positive. When one parent was
infected, 92% of the children tested were positive. Most people on our
Registry report close relatives or friends as becoming symptomatic. Even
pets get sick and die. Registry's Recommendations Before the cold war,
people who had CFS were suffering from a naturally occurring type of mycoplasma.
Mycoplasma fermentans incognitus is a genetically altered biological weapon
made more virulent, more drug resistant and more contagious. The Department
of Defense owns the patents to it. The CDC and NIH have know about mycoplasmas
for many years, having worked with the DoD. The only thing that has changed
is that now, we the victims, know about it too.
1. CDC must reclassify mycoplasmas as a reportable contagious disease if
found in blood/ 2. FDA must test all vaccines for mycoplasma contamination.
3. Blood supplies must be tested routinely for mycoplasmas, as is now done
for HIV.
4. All military personal must be tested for mycoplasmas.
5. Health care workers, teachers and students must be tested for mycoplasma
infection.
6. NIH must fund studies for mycoplasma research.
7. All Gulf War Illness research must be taken away from the DoD.
8. All CFS, GWI, and Fibromyalgia patients should be tested for contagious
diseases such as: Mycoplasma, Chlamydia, Brucella, Streptococcus and HHV-6
9. Family members and pets of those infected should be tested and treated.
Mycoplasma Registry 303 N 47th Street, J-10 San Diego, CA 92102-5961 telephone:
619-266-1116 e-mail: mycoreg@juno.com © 1999
FAIR USE NOTICE.
Some of the information on this web site consists of copyrighted materials
which use has not been specifically authorized by the copyright owner. We
are making this material available in an effort to advance the widespread
understanding of public health issues. We believe this constitutes a 'fair
use' of the copyrighted material as provided for in Section 107 of the US
Copyright Law. If you wish to use such copyrighted material for purposes
of your own that go beyond 'fair use' you must obtain permission from the
copyright owner. If you are the copyright owner and wish to comment
on this practice please feel free to contact us, your input is greatly appreciated.
In accordance with Title 17 U.S.C. Section 107, the material on this site
is distributed without profit to those who have expressed a prior interest
in receiving the included information for research and educational purposes.
For more information about fair use please go to: http://www.law.cornell.edu/
uscode/17/107.shtml
|